Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4507531000168117 | Memantine (LAPL) (memantine hydrochloride 5 mg) tablet, 7 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4507541000168114 | Memantine (LAPL) 5 mg tablet, 7, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Memantine (LAPL) 5 mg tablet, 7, blister pack | Is a | Memantine (LAPL) 5 mg tablet, 7 | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 7, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 7, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 7, blister pack | has TP | Memantine (LAPL) | true | Inferred relationship | Some | ||
| Memantine (LAPL) 5 mg tablet, 7, blister pack | has TPUU | Memantine (LAPL) 5 mg tablet | true | Inferred relationship | Some | 988215249 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR